Can we control tuberculosis in high HIV prevalence settings?
- PMID: 12758192
- DOI: 10.1016/s1472-9792(02)00083-5
Can we control tuberculosis in high HIV prevalence settings?
Abstract
The overlap between the epidemiology of HIV and tuberculosis and consequent rapid rise in numbers of patients with tuberculosis in many African countries has put a huge burden on health systems. The stigma of HIV has increased the existing stigma surrounding tuberculosis. There are three mechanisms by which we may reduce the number of cases of tuberculosis in a community: reducing transmission of tuberculosis, reducing reactivation of latent tuberculosis infection and reducing HIV transmission. Reinforcing the existing health service to find more cases, active case-finding in communities or enhanced case-finding in specific groups will reduce transmission of tuberculosis. However, health services that find it difficult to find cases efficiently will also find it difficult to support patients throughout treatment to achieve a cure. Partnership with traditional healers, community-based organizations and private practitioners could reduce this burden. Reactivation of tuberculosis among people living with HIV can be reduced by tuberculosis preventive therapy or by antiretroviral therapy. Programmes that identify people living with HIV can also implement enhanced tuberculosis case-finding increasing the benefits of the programme. However, the impact of widespread use of antiretroviral therapy may be to increase the number of people in a community who are mildly immunocompromised and the incidence of tuberculosis at a community level might rise. Any strategy that successfully reduces HIV transmission will benefit tuberculosis control, since around a third of all HIV-positive individuals will develop tuberculosis before they die. To control tuberculosis in high HIV prevalence settings, we must strengthen health systems to include not only expansion of the DOTS strategy but also full-blooded implementation of voluntary counselling and testing, enhanced and active tuberculosis case-finding, preventive therapy and better care for people living with HIV including antiretroviral therapy. The approach needed to control tuberculosis needs also to be integrated into broader development and poverty reduction goals.
Similar articles
-
Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.Int J Tuberc Lung Dis. 1999 Jun;3(6):457-65. Int J Tuberc Lung Dis. 1999. PMID: 10383056 Review.
-
[Tuberculosis in Asia].Kekkaku. 2002 Oct;77(10):693-7. Kekkaku. 2002. PMID: 12440145 Japanese.
-
Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries.Bull World Health Organ. 2002;80(3):217-27. Bull World Health Organ. 2002. PMID: 11984608 Free PMC article. Review.
-
Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.Bull World Health Organ. 1997;75(5):477-89. Bull World Health Organ. 1997. PMID: 9447782 Free PMC article. Review.
-
Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.AIDS. 1995 Mar;9(3):267-73. AIDS. 1995. PMID: 7755915
Cited by
-
Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia.BMC Res Notes. 2015 Sep 29;8:503. doi: 10.1186/s13104-015-1452-x. BMC Res Notes. 2015. PMID: 26420164 Free PMC article.
-
Clinical relevance of Mycobacterium tuberculosis plcD gene mutations.Am J Respir Crit Care Med. 2005 Jun 15;171(12):1436-42. doi: 10.1164/rccm.200408-1147OC. Epub 2005 Apr 1. Am J Respir Crit Care Med. 2005. PMID: 15805187 Free PMC article.
-
Stigma matters in ending tuberculosis: Nationwide survey of stigma in Ethiopia.BMC Public Health. 2020 Feb 6;20(1):190. doi: 10.1186/s12889-019-7915-6. BMC Public Health. 2020. PMID: 32028914 Free PMC article.
-
ZAMSTAR, The Zambia South Africa TB and HIV Reduction Study: design of a 2 x 2 factorial community randomized trial.Trials. 2008 Nov 7;9:63. doi: 10.1186/1745-6215-9-63. Trials. 2008. PMID: 18992133 Free PMC article.
-
Tuberculosis and stigmatization: pathways and interventions.Public Health Rep. 2010 Jul-Aug;125 Suppl 4(Suppl 4):34-42. doi: 10.1177/00333549101250S407. Public Health Rep. 2010. PMID: 20626191 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical